Upsher-Smith Laboratories, LLC Sustainability Profile
Upsher-Smith Laboratories, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1976, the company has established itself as a leader in the development and manufacturing of generic and specialty pharmaceuticals, with a focus on areas such as neurology, dermatology, and women's health. With a commitment to quality and innovation, Upsher-Smith offers a diverse portfolio of products, including oral solid dosage forms and injectables, which are distinguished by their reliability and efficacy. The company has achieved significant milestones, including the expansion of its manufacturing capabilities and a robust pipeline of new therapies. Recognised for its dedication to patient care and community health, Upsher-Smith continues to strengthen its market position through strategic partnerships and a focus on underserved therapeutic areas.
DitchCarbon Score
How does Upsher-Smith Laboratories, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Upsher-Smith Laboratories, LLC's score of 30 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Upsher-Smith Laboratories, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Bora Pharmaceuticals Co., LTD., which may influence its climate commitments and reporting practices. As of now, Upsher-Smith Laboratories has not established any documented reduction targets or initiatives related to carbon emissions. There are no specific commitments to the Science Based Targets initiative (SBTi) or other climate pledges that are publicly available. Given the lack of direct emissions data and reduction initiatives, it is essential to consider the broader context of the pharmaceutical industry, which is increasingly focusing on sustainability and carbon footprint reduction. Companies in this sector are often encouraged to adopt comprehensive climate strategies to mitigate their environmental impact. In summary, while Upsher-Smith Laboratories, LLC does not currently provide emissions data or specific climate commitments, its affiliation with Bora Pharmaceuticals Co., LTD. may play a role in shaping its future sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 12,649,345.4 | 00,000,000.0 | 0,000,000 | 0,000,000.0 |
| Scope 2 | 10,015,185.2 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 21,525,110.2 | - | - | 0,000,000.0 |
How Carbon Intensive is Upsher-Smith Laboratories, LLC's Industry?
How Carbon Intensive is Upsher-Smith Laboratories, LLC's Location?
Upsher-Smith Laboratories, LLC's Scope 3 Categories Breakdown
Upsher-Smith Laboratories, LLC's Scope 3 emissions, which decreased by 75% last year and decreased by approximately 75% since 2021, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 16% of total emissions under the GHG Protocol, with "Employee Commuting" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
Upsher-Smith Laboratories, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Upsher-Smith Laboratories, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
